350 related articles for article (PubMed ID: 24916280)
1. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.
Fujita W; Gomes I; Devi LA
Br J Pharmacol; 2014 Sep; 171(18):4155-76. PubMed ID: 24916280
[TBL] [Abstract][Full Text] [Related]
2. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.
Fujita W; Gomes I; Devi LA
Br J Pharmacol; 2015 Jan; 172(2):375-87. PubMed ID: 24571499
[TBL] [Abstract][Full Text] [Related]
3. Opioid-receptor-heteromer-specific trafficking and pharmacology.
van Rijn RM; Whistler JL; Waldhoer M
Curr Opin Pharmacol; 2010 Feb; 10(1):73-9. PubMed ID: 19846340
[TBL] [Abstract][Full Text] [Related]
4. Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.
Gomes I; Fujita W; Chandrakala MV; Devi LA
Prog Mol Biol Transl Sci; 2013; 117():207-65. PubMed ID: 23663971
[TBL] [Abstract][Full Text] [Related]
5. In vivo opioid receptor heteromerization: where do we stand?
Massotte D
Br J Pharmacol; 2015 Jan; 172(2):420-34. PubMed ID: 24666391
[TBL] [Abstract][Full Text] [Related]
6. Opioid receptor heteromers in analgesia.
Costantino CM; Gomes I; Stockton SD; Lim MP; Devi LA
Expert Rev Mol Med; 2012 Apr; 14():e9. PubMed ID: 22490239
[TBL] [Abstract][Full Text] [Related]
7. GPCR heteromers: An overview of their classification, function and physiological relevance.
Dale NC; Johnstone EKM; Pfleger KDG
Front Endocrinol (Lausanne); 2022; 13():931573. PubMed ID: 36111299
[TBL] [Abstract][Full Text] [Related]
8. Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology.
Stockton SD; Devi LA
Drug Alcohol Depend; 2012 Mar; 121(3):167-72. PubMed ID: 22115888
[TBL] [Abstract][Full Text] [Related]
9. Evidence and Function Relevance of Native DOR-MOR Heteromers.
Cahill CM; Ong E
Handb Exp Pharmacol; 2018; 247():115-127. PubMed ID: 29633181
[TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled heteromers: regulation in disease.
Gomes I; Gupta A; Devi LA
Methods Enzymol; 2013; 521():219-38. PubMed ID: 23351742
[TBL] [Abstract][Full Text] [Related]
11. Heteromerization Modulates mu Opioid Receptor Functional Properties
Ugur M; Derouiche L; Massotte D
Front Pharmacol; 2018; 9():1240. PubMed ID: 30483121
[TBL] [Abstract][Full Text] [Related]
12. [MOPr-DOPr heteromer: the meaning and possibility as novel therapeutic target for pain control].
Fujita W
Nihon Yakurigaku Zasshi; 2021; 156(3):134-138. PubMed ID: 33952839
[TBL] [Abstract][Full Text] [Related]
13. Agonists at the δ-opioid receptor modify the binding of µ-receptor agonists to the µ-δ receptor hetero-oligomer.
Kabli N; Martin N; Fan T; Nguyen T; Hasbi A; Balboni G; O'Dowd BF; George SR
Br J Pharmacol; 2010 Nov; 161(5):1122-36. PubMed ID: 20977461
[TBL] [Abstract][Full Text] [Related]
14. Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.
Schuster DJ; Metcalf MD; Kitto KF; Messing RO; Fairbanks CA; Wilcox GL
Br J Pharmacol; 2015 Jan; 172(2):642-53. PubMed ID: 24827408
[TBL] [Abstract][Full Text] [Related]
15. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function.
Gomes I; Gupta A; Bushlin I; Devi LA
Front Pharmacol; 2014; 5():268. PubMed ID: 25520661
[TBL] [Abstract][Full Text] [Related]
17. G protein-coupled receptor heteromers are key players in substance use disorder.
Derouiche L; Massotte D
Neurosci Biobehav Rev; 2019 Nov; 106():73-90. PubMed ID: 30278192
[TBL] [Abstract][Full Text] [Related]
18. Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain.
Bushlin I; Gupta A; Stockton SD; Miller LK; Devi LA
PLoS One; 2012; 7(12):e49789. PubMed ID: 23272051
[TBL] [Abstract][Full Text] [Related]
19. Arrestin recruitment and signaling by G protein-coupled receptor heteromers.
Mores KL; Cassell RJ; van Rijn RM
Neuropharmacology; 2019 Jul; 152():15-21. PubMed ID: 30419245
[TBL] [Abstract][Full Text] [Related]
20. Exploring a role for heteromerization in GPCR signalling specificity.
Rozenfeld R; Devi LA
Biochem J; 2011 Jan; 433(1):11-8. PubMed ID: 21158738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
